tradingkey.logo

BRIEF-TC Biopharm's Data Show A Favorable Response In Patients With Relapse Or Refractory AML

ReutersFeb 13, 2025 1:44 PM

- TC Biopharm (Holdings) PLC T0Uy.F:

  • TCBP ANNOUNCES SUCCESSFUL COMPLETION OF COHORT A IN THE ACHIEVE CLINICAL TRIAL

  • TC BIOPHARM- AVAILABLE DATA SHOW A FAVORABLE SAFETY & EFFICACY RESPONSE IN COHORT A PATIENTS, PATIENTS WITH RELAPSE OR REFRACTORY AML

  • TC BIOPHARM (HOLDINGS) PLC - NO DRUG-RELATED ADVERSE EVENTS IN COHORT A PATIENTS

Source text: ID:nPn5l9x6Xa

Further company coverage: [T0Uy.F]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI